share_log

HC Wainwright & Co. Maintains Buy on Rani Therapeutics Hldgs, Lowers Price Target to $12

Moomoo 24/7 ·  Mar 25 06:06

HC Wainwright & Co. analyst Mitchell Kapoor maintains Rani Therapeutics Hldgs (NASDAQ:RANI) with a Buy and lowers the price target from $16 to $12.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment